New class of molecules may protect brain from stroke, neurodegenerative diseases

September 28, 2017
Credit: Louisiana State University

Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered a new class of molecules in the brain that synchronize cell-to-cell communication and neuroinflammation/immune activity in response to injury or diseases. Elovanoids (ELVs) are bioactive chemical messengers made from omega-3 very long chain polyunsaturated fatty acids (VLC-PUFAs,n-3). They are released on demand when cells are damaged or stressed.

"Although we knew about messengers from such as neuroprotectin D1 (22 carbons) before, the novelty of the present discovery is that elovanoids are made of 32 to 34 carbon atoms in length," notes Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans. "We expect that these structures will profoundly increase our understanding of cellular cross talk to sustain neuronal circuitry and particularly to restore cell equilibrium after pathological insults."

Working in neuronal cell cultures from the cerebral cortex and from the hippocampus and a model of , the researchers found that elovanoids not only protected neuronal and promoted their survival, but helped maintain their integrity and stability. The work is published in Science Advances.

"Our findings represent a breakthrough in the understanding of how the complexity and resiliency of the are sustained when confronted with adversities such as , Parkinson's or Alzheimer's and neuroprotection signaling needs to be activated," says Dr. Bazan. "A key factor is how neurons communicate among themselves. These novel molecules participate in communicating messages to overall synaptic organization to ensure an accurate flow of information through neuronal circuits. We know how neurons make synaptic connections with other neurons, however these connections have to be malleable to change strength appropriately. Elovanoids might play a central role as synaptic organizers, especially important in conditions resulting from synaptic dysfunction such as autism or amyotropic lateral sclerosis, for which we have no therapeutic answers."

Although the occurrence of very long chain polyunsaturated has been well documented, what has not been known is their significance and potential to be converted into biochemical triggers to resolve injury, inflammation and other threats to neuronal communication and cell survival.

Dr. Nicolas G. Bazan. Credit: LSU Health New Orleans Neuroscience Center of Excellence

The researchers discovered the structure and characteristics of two elovanoids - ELV-N32 and ELV-N34 - in the brain. Starting with neuron cell cultures and then an experimental model of stroke, they found that elovanoids were activated when cells underwent either oxygen/glucose deprivation or excitotoxicity - early events associated with stroke, epilepsy, Parkinson's, and other . They determined the concentrations and therapeutic windows at which elovanoids conferred neuroprotection. The team found that elovanoids overcame the damaging effects and toxicity of these early events. In the stroke model, elovanoids reduced the size of the damaged brain area, initiated repair mechanisms and improved neurological/behavioral recovery.

"Our findings provide a major conceptual advance of broad relevance for neuronal cell survival and brain function, particularly in regards to ischemic stroke," adds Bazan. "In the near future, we hope to apply this knowledge to prevent traumatic brain injury, chronic traumatic encephalopathy, stroke and neurodegenerative diseases. Elovanoids may offer an answer to be tested as a potential therapy."

Explore further: Newly discovered elovanoids called a 'transformative new concept of biology'

More information: Surjyadipta Bhattacharjee et al, Elovanoids are a novel class of homeostatic lipid mediators that protect neural cell integrity upon injury, Science Advances (2017). DOI: 10.1126/sciadv.1700735

Related Stories

Newly discovered elovanoids called a 'transformative new concept of biology'

July 13, 2017
Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered a new class of mediators, or biochemical triggers that he named elovanoids ...

Using omega 3 fatty acids to treat Alzheimer's, other diseases?

July 18, 2017
Understanding how dietary essential fatty acids work may lead to effective treatments for diseases and conditions such as stroke, Alzheimer's disease, age-related macular degeneration, Parkinson's disease and other retinal ...

Research shows fish oil component helps damaged brain and retina cells survive

April 21, 2017
A team of researchers led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans School of Medicine, has shown for the first time that NDP1, a signaling molecule ...

Does brain tissue regeneration depend on maturity of stem cells used for transplantation?

September 13, 2017
New research has shown that the success of transplanting stem cells into the brain to regenerate tissue damaged by stroke may depend on the maturity of the neuronal precursor cells used for transplantation. A study demonstrating ...

Team discovers key to preventing blindness and stroke devastation

January 30, 2015
Research led by Nicolas Bazan, MD, PhD, Boyd Professor, Ernest C. and Yvette C. Villere Chair of Retinal Degeneration Research, and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered ...

New research discovers key to survival of brain cells

September 28, 2011
Nicolas G. Bazan, MD, Ph.D, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center New Orleans, and David Stark, an MD/Ph.D student working in his lab, have discovered how a key ...

Recommended for you

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Study reveals key molecular link in major cell growth pathway

October 19, 2017
A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate growth with how they sense and make available the nutrients required for growth. Their work, which ...

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Knowmost
not rated yet Sep 28, 2017
When 98% of all strokes are caused by carotid artery calcification, why not prevernt? Lower causative homocysteine with high butter/cream intake, to synthesize B Vtis, in the gut (B6, B12, Folates needed) (Malhotra S ,L Dr . Lancet 11X), Stop inflammation that's a cause with anti-oxidants in 2 egg yolks daily, eat grass fed anima fats for protective Om3, CLA. LCFAs. Idiotic mainstream advice is..lower/zero these.
Knowmost
not rated yet Sep 28, 2017
And lower causative triglycerides, blood fats elevated by too much carbs especially sugar, and.. alcohol. Stop damaging neurons with aluminum which creates neuro-fibrillary tangles, NFT, the DEATH of the brain's neuron. Al is in toothpaste, (unmarked), cookware, cook-foils, vax, deodarants. Take a teaspoon of curcumin with a pinch of black pepper with 2 meals to boost your BDN-factor which repairs damaged neurons.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.